Federation Des Caisses Desjardins Du Quebec Ab Cellera Biologics Inc. Transaction History
Federation Des Caisses Desjardins Du Quebec
- $23.7 Billion
- Q3 2025
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 43,656 shares of ABCL stock, worth $161,090. This represents 0.0% of its overall portfolio holdings.
Number of Shares
43,656
Previous 17,300
152.35%
Holding current value
$161,090
Previous $59,000
271.19%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding ABCL
# of Institutions
169Shares Held
109MCall Options Held
1.26MPut Options Held
788K-
Baker Bros. Advisors LP New York, NY27.5MShares$102 Million1.13% of portfolio
-
Capital World Investors Los Angeles, CA13.4MShares$49.3 Million0.01% of portfolio
-
Baillie Gifford & CO10.4MShares$38.5 Million0.04% of portfolio
-
Two Sigma Investments, LP New York, NY5.18MShares$19.1 Million0.04% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny4.8MShares$17.7 Million0.05% of portfolio
About AbCellera Biologics Inc.
- Ticker ABCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 285,139,008
- Market Cap $1.05B
- Description
- AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...